| Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients (NCT04680624) | Association pour la Recherche Clinique et Immunologique | 2021-01-01 |
| Efficacy of Roflumilast in the Treatment of Psoriasis (NCT04549870) | Bispebjerg Hospital | 2021-01-01 |
| Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab (NCT04533737) | LEO Pharma | 2020-12-17 |
| Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis (NCT04811911) | Aswan University Hospital | 2020-12-13 |
| the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis (NCT04912401) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-12-04 |
| Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients (NCT04765332) | Clinact | 2020-12-04 |
| Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients (NCT04633616) | University of Southern California | 2020-11-16 |
| Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System (NCT04410237) | University Hospitals Cleveland Medical Center | 2020-11-04 |
| An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound (NCT04488185) | Novartis Pharmaceuticals | 2020-11-02 |
| Dietary Perceptions and Practices in Chinese Psoriasis Patients (NCT05118425) | Xijing Hospital | 2020-11-01 |
| Tofacitinib for Immune Skin Conditions in Down Syndrome (NCT04246372) | University of Colorado, Denver | 2020-10-21 |
| Modified Intermittent Fasting in Psoriasis (NCT04418791) | University Hospital, Ghent | 2020-10-17 |
| Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients (NCT04435730) | Assiut University | 2020-10-15 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response (NCT05051943) | Fresenius Kabi | 2020-09-29 |
| A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants (NCT04316585) | GlaxoSmithKline | 2020-09-28 |
| A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis (NCT04603027) | Evelo Biosciences, Inc. | 2020-09-21 |
| Predicting Medication Response for Autoimmune Disease (NCT04995783) | Coral Genomics, Inc. | 2020-09-01 |
| Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis (NCT04271735) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-08-26 |
| Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (NCT04340076) | Radboud University Medical Center | 2020-08-20 |
| PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis (NCT04513847) | Dermatrials Research | 2020-08-13 |
| A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated (NCT05683054) | University Hospital, Ghent | 2020-08-11 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects (NCT04371185) | Bio-Thera Solutions | 2020-08-08 |
| Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis (NCT04433442) | AbbVie | 2020-08-04 |
| Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome (NCT04469829) | Universita di Verona | 2020-08-01 |
| Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis (NCT04308616) | University Hospital, Tours | 2020-07-20 |
| A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms (NCT04435600) | AbbVie | 2020-07-14 |
| Chinese Psoriasis Real World Evidence Research (NCT04465838) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-07-08 |
| The Maintenance Effect of Enstilar Foam in Combination With Otezla (NCT04555707) | Derm Research, PLLC | 2020-06-24 |
| A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis (NCT04439526) | Janssen-Cilag S.p.A. | 2020-06-10 |
| Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis (NCT04414605) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2020-06-04 |
| The Anti-inflammatory Effects of Harkány Medicinal Water (NCT04275206) | University of Pecs | 2020-06-01 |
| Adalimumab Biosimilar in Clinical Practice (NCT04808739) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2020-06-01 |
| Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis (NCT04344574) | Assiut University | 2020-06-01 |
| A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis (NCT05504317) | Akeso | 2020-05-28 |
| Taltz in Combination With Enstilar for Psoriasis (NCT04372277) | Psoriasis Treatment Center of Central New Jersey | 2020-04-28 |
| ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. (NCT04347473) | Psoriasis Treatment Center of Central New Jersey | 2020-04-06 |
| MIcrovascular dysfuNction In Moderate-severe Psoriasis (NCT04271540) | Marcelo F. Di Carli, MD, FACC | 2020-04-04 |
| Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients (NCT04275024) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2020-04-01 |
| Work Stress and Impact of Pruritus on Quality of Life (NCT04316533) | University Hospital, Brest | 2020-03-09 |
| A Pilot Study to Explore the Role of Gut Flora in Psoriasis (NCT04099979) | ProgenaBiome | 2020-03-02 |
| Evaluating of New Screening Tool for Arthritis* in Psoriasis (NCT04277832) | Bezmialem Vakif University | 2020-02-21 |
| Non-pharmacological Mitigation of Psoriasis (NCT04745429) | Medical University of Lodz | 2020-02-19 |
| Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal Complains (NCT04074070) | Assistance Publique - Hôpitaux de Paris | 2020-02-18 |
| Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis (NCT04274595) | Centre Hospitalier Universitaire de Nīmes | 2020-02-13 |
| The Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (NCT05858099) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2020-01-30 |
| Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases (NCT04200690) | University of Aarhus | 2020-01-14 |
| Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata (NCT03976622) | University Hospital, Bordeaux | 2020-01-14 |
| HIV Indicator Diseases in Hospital and Primary Care (NCT05225493) | Erasmus Medical Center | 2020-01-01 |
| GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden (NCT04190758) | Vastra Gotaland Region | 2020-01-01 |
| A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis (NCT04175613) | Amgen | 2019-12-20 |
| Evolution and Treatments of Chronic Inflammatory Systemic Diseases (NCT04191395) | Centre Hospitalier Universitaire de Besancon | 2019-12-11 |
| Ayurvedic Treatment Package in Plaque Psoriasis (NCT04146558) | Universität Duisburg-Essen | 2019-12-04 |
| A Study of LY3471851 in Participants With Psoriasis (NCT04119557) | Nektar Therapeutics | 2019-11-26 |
| An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea (NCT04167462) | Bristol-Myers Squibb | 2019-11-25 |
| A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis (NCT04152382) | Eli Lilly and Company | 2019-11-20 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 (NCT03580278) | Affibody | 2019-11-13 |
| A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis (NCT03987763) | Bausch Health Americas, Inc. | 2019-10-22 |
| Impact of Decision-Framing in Psoriasis (NCT04136314) | University of Southern California | 2019-10-21 |
| Duobrii in Combination With Biologics (NCT04119102) | Psoriasis Treatment Center of Central New Jersey | 2019-10-14 |
| Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath (NCT04117919) | China Medical University Hospital | 2019-10-05 |
| A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen (NCT04149587) | Bausch Health Americas, Inc. | 2019-09-30 |
| A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 (NCT04106297) | Lakefront Biotherapeutics NV | 2019-09-10 |
| A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis (NCT03998683) | Janssen-Cilag Ltd. | 2019-09-03 |
| Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt (NCT04039451) | Assiut University | 2019-09-01 |
| Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial (NCT04071106) | Zagazig University | 2019-09-01 |
| Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis (NCT04036435) | Bristol-Myers Squibb | 2019-08-12 |
| Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study) (NCT04058652) | Wake Forest University Health Sciences | 2019-08-07 |
| Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis (NCT03392311) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2019-07-23 |
| Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal) (NCT04013867) | University Hospital, Clermont-Ferrand | 2019-07-22 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis (NCT03718299) | Sun Pharmaceutical Industries Limited | 2019-07-16 |
| The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis (NCT03526705) | Cairo University | 2019-07-15 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis (NCT03895372) | Pfizer | 2019-06-27 |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease (NCT03656627) | Alliance Foundation Trials, LLC. | 2019-06-27 |
| Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea (NCT03925441) | AbbVie | 2019-06-25 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis (NCT03922607) | AbbVie | 2019-06-11 |
| MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool (NCT04168619) | The University of Hong Kong | 2019-06-10 |
| Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (NCT03816917) | Radboud University Medical Center | 2019-06-01 |
| Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study (NCT03942185) | Shanghai Yueyang Integrated Medicine Hospital | 2019-06-01 |
| A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis (NCT02970331) | Maruho Co., Ltd. | 2019-06-01 |
| Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis (NCT04102241) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-05-30 |
| A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis (NCT03875482) | AbbVie | 2019-05-13 |
| A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (NCT03542994) | Evelo Biosciences, Inc. | 2019-04-24 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis (NCT03960450) | Boston Pharmaceuticals | 2019-04-23 |
| Skin Microbial Ecology in Atopic Dermatitis (NCT04170244) | University of Rochester | 2019-04-17 |
| An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis (NCT03924427) | Bristol-Myers Squibb | 2019-04-10 |
| Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis (NCT03850483) | Pfizer | 2019-04-08 |
| A Clinical Investigation With Epaderm® Cream (NCT03738163) | Molnlycke Health Care AB | 2019-04-01 |
| Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients (NCT03904680) | Cairo University | 2019-04-01 |
| Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis (NCT03889938) | Assiut University | 2019-04-01 |
| Mind-Body Approaches for Medical Conditions (NCT03888261) | University Hospital, Gentofte, Copenhagen | 2019-04-01 |
| A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life (NCT03774875) | Amgen | 2019-03-28 |
| Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (NCT03768219) | Aptevo Therapeutics | 2019-03-18 |
| A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is (NCT03835481) | Boehringer Ingelheim | 2019-03-18 |
| Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy (NCT03721172) | Amgen | 2019-03-11 |
| The Inner Ear Function in Psoriatic Patients (NCT03865030) | HaEmek Medical Center, Israel | 2019-03-01 |
| Light Treatment Effectiveness (LITE) Study (NCT03726489) | University of Pennsylvania | 2019-03-01 |
| Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells (NCT03765957) | Central South University | 2019-02-20 |